SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-16-138920
Filing Date
2016-08-11
Accepted
2016-08-11 12:10:20
Documents
3
Period of Report
2016-08-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a16-16608_18k.htm 8-K 26636
2 EX-99.1 a16-16608_1ex99d1.htm EX-99.1 6474
3 GRAPHIC g166081mmi001.jpg GRAPHIC 2723
  Complete submission text file 0001104659-16-138920.txt   38320
Mailing Address 500 OFFICE CENTER DRIVE, SUITE 400 FORT WASHINGTON PA 19034
Business Address 500 OFFICE CENTER DRIVE, SUITE 400 FORT WASHINGTON PA 19034 610-527-6790
MADRIGAL PHARMACEUTICALS, INC. (Filer) CIK: 0001157601 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33277 | Film No.: 161823658
SIC: 2834 Pharmaceutical Preparations